Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma.
Authors: Chou WH; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA., Lawrence L; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA., Neham E; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Akilesh S; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA., Moran AE; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Corless CL; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239, USA., Langmesser L; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA., Cengiz B; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Eckenstein K; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Liu JJ; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Isharwal S; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Amling CL; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Strother MC; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA., Chakiryan NH; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Urology, Portland VA Medical Center, Portland, OR 97239, USA., Thomas GV; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239, USA.
Source: Cancers [Cancers (Basel)] 2026 Jan 20; Vol. 18 (2). Date of Electronic Publication: 2026 Jan 20.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41595231
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chou+WH%22">Chou WH</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Lawrence+L%22">Lawrence L</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Neham+E%22">Neham E</searchLink>; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Akilesh+S%22">Akilesh S</searchLink>; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.<br /><searchLink fieldCode="AU" term="%22Moran+AE%22">Moran AE</searchLink>; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Corless+CL%22">Corless CL</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Langmesser+L%22">Langmesser L</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Cengiz+B%22">Cengiz B</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Eckenstein+K%22">Eckenstein K</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Liu+JJ%22">Liu JJ</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Isharwal+S%22">Isharwal S</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Amling+CL%22">Amling CL</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Strother+MC%22">Strother MC</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Chakiryan+NH%22">Chakiryan NH</searchLink>; Department of Urology, Oregon Health & Science University, Portland, OR 97239, USA.; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Urology, Portland VA Medical Center, Portland, OR 97239, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+GV%22">Thomas GV</searchLink>; Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR 97239, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2026 Jan 20; Vol. 18 (2). <i>Date of Electronic Publication: </i>2026 Jan 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41595231
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers18020312
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chou WH
      – PersonEntity:
          Name:
            NameFull: Lawrence L
      – PersonEntity:
          Name:
            NameFull: Neham E
      – PersonEntity:
          Name:
            NameFull: Akilesh S
      – PersonEntity:
          Name:
            NameFull: Moran AE
      – PersonEntity:
          Name:
            NameFull: Corless CL
      – PersonEntity:
          Name:
            NameFull: Langmesser L
      – PersonEntity:
          Name:
            NameFull: Cengiz B
      – PersonEntity:
          Name:
            NameFull: Eckenstein K
      – PersonEntity:
          Name:
            NameFull: Liu JJ
      – PersonEntity:
          Name:
            NameFull: Isharwal S
      – PersonEntity:
          Name:
            NameFull: Amling CL
      – PersonEntity:
          Name:
            NameFull: Strother MC
      – PersonEntity:
          Name:
            NameFull: Chakiryan NH
      – PersonEntity:
          Name:
            NameFull: Thomas GV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 01
              Text: 2026 Jan 20
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2072-6694
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1